Sleep Apnea Devices MarketPosted by ahila on April 30th, 2018 Global Sleep Apnea Devices market is a chronic disorder, characterized with repetitive obstructions in breathing during sleep. Major symptoms include snoring, gasping or choking. Long-term health problems associated with OSA include cardiovascular disorders, memory and cognitive problems, glaucoma, depression and mood disorders. Polysomnography and portable home sleep diagnostic devices are enabling diagnose the Obstructive sleep apnea (OSA). First line therapy for involves positive airway devices(PAP). If patients do not respond to the PAP therapy, second-line treatment includes dental appliances and surgery. Rapid traction in the global geriatric population coupled with increased obesity levels enables to increase the prevalence of sleep apnea. The world is experiencing growth in the number and proportion of old age people. As per WHO, the number of people aged 60 years or over is projected to grow approximately 56 % between 2015 to 2030. According to estimates, a prevalence of OSA is approximately 3% to 7% of the adult men and 2 to 5% of adult women. Moreover, 80% of the patients with moderate to severe sleep apnea may be undiagnosed. A sample of this report is available upon request @ Global sleep apnea devices market by product can be segmented as therapeutic devices, diagnostic devices. Therapeutic sleep apea devices market expected to expand at significant CAGR due to adoption of advanced technologies to treat OSA. CPAP devices are most commonly used devices to treat OSA, the pressure delivered to the airway is same during both inhalation and exhalation. Diagnostic devices include polysomnography, respiratory polygraph devices. Actigraph devices is expected to expand at significant CAGR. These devices enable measure motions of the body and assess real world sleep/ wake patterns. To view TOC of this report is available upon request @ Like it? Share it! More by this author |